| Molecular Formula | C10H17BN2O2 |
| Molar Mass | 208.07 |
| Density | 1.05±0.1 g/cm3(Predicted) |
| Melting Point | 59-64°C(lit.) |
| Boling Point | 308.3±15.0 °C(Predicted) |
| Flash Point | 140.272°C |
| Water Solubility | Slightly soluble in water. |
| Solubility | Chloroform (slightly), Methanol (Slightly) |
| Vapor Presure | 0.001mmHg at 25°C |
| Appearance | Crystalline powder |
| Color | Off-white to yellow |
| pKa | 2.09±0.10(Predicted) |
| Storage Condition | Keep in dark place,Sealed in dry,Room Temperature |
| Refractive Index | 1.505 |
| MDL | MFCD03789259 |
| Risk Codes | R22 - Harmful if swallowed R36/37/38 - Irritating to eyes, respiratory system and skin. |
| Safety Description | S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. S36 - Wear suitable protective clothing. S37/39 - Wear suitable gloves and eye/face protection |
| WGK Germany | 3 |
| TSCA | No |
| HS Code | 29349990 |
| Hazard Note | Irritant/Flammable |
| Hazard Class | IRRITANT |
| Use | 1-methyl -4-(4,4,5, 5-tetramethyl-1, 3, 2-dioxopentaboran-2-yl)-1H-pyrazole is a reagent for drug synthesis, including the preparation of a selective and orally bioavailable LRRK2 inhibitor for the treatment of Parkinson's disease. 1-methylpyrazol-4-boronic acid pinacyl Ester is an agent for drug synthesis, including the preparation of a selective and orally bioavailable LRRK2 inhibitor for the treatment of Parkinson's disease. |
| Application | 1-methyl -4-(4,4,5, 5-tetramethyl-1, 3, 2-dioxopentboran-2-yl)-1H-pyrazole is an intermediate in organic synthesis and pharmaceutical research and development, which can be used in laboratory research and development. |